In The News
ASIC takes NAB to court over customer hardship claims
Seven settles lawsuit by ex-Spotlight reporter
Court OKs stolen wages settlement, holds off on ‘eye-watering’ fees
Settlement reached with ‘highly unethical’ mastermind of Banksia class action
Full Court cites ‘wider relevance’ of copy and paste judgment
DWF snags 9 partners from Hall & Wilcox
Tasmanian judge found to have assaulted fiance spared jail time
Barristers acting on instructions from solicitor to be exempt from AML/CTF regime
ASX denies misleading investors about CHESS replacement project
Judge worries compensation for axed Qantas ground crew ‘going off into never never’
Please login to bookmarkClose

Novartis has lost its bid to have Pharmacor’s claim that its patent for a blood pressure drug is invalid decided ahead of a main trial where the Swiss pharmaceutical giant will allege the generic drug maker is threatening to infringe its patent. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au